Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.
Retinal toxicity is damage to retinal cells caused by a drug, chemical, radiation, or intense light exposure. The injury often affects the macula, so reading and fine detail vision can be affected first. Some toxic effects develop slowly with long-term medication use, while others follow a single high exposure. Early detection matters because some forms can progress even after the exposure stops.
read more about retinal toxicity ...Medicines are a common cause, with hydroxychloroquine and chloroquine being well-known examples linked to toxic retinopathy. Other drugs such as pentosan polysulfate and tamoxifen have also been linked with macular injury in some patients. Radiation to the eye area and intense light exposure, including sun-gazing or certain laser and welding exposures, can injure retinal tissue. Some toxins and metabolic issues can also damage the retina, especially when the exposure is repeated. A medication list and exposure history are central to identifying the cause.
Early retinal toxicity can be subtle and can be missed without screening in higher-risk medication users. Symptoms can include trouble reading, reduced contrast, and a blurry or dim area near the center of vision. Some people notice paracentral blind spots that make words look like letters are missing. Color vision can look less accurate, and bright light can feel more uncomfortable when the macula is affected. Sudden symptoms after intense light exposure should be checked right away because retinal injury can occur quickly.
Diagnosis starts with a dilated retina exam and a review of medication dose, duration, and risk factors such as kidney disease. Optical coherence tomography (OCT) can show early layer changes in the macula before obvious vision loss develops. Automated visual field testing can map paracentral or pericentral defects that match toxic patterns. Fundus autofluorescence and multifocal electroretinography can add supportive data when the diagnosis is uncertain. Monitoring plans vary by drug and risk profile, so screening is tailored to the individual situation.
Management focuses on stopping or reducing the offending exposure in coordination with the prescribing clinician when a medication is involved. Retinal damage from drug toxicity is often not reversible, so the goal is to limit further injury and track progression. Follow-up imaging and visual fields help monitor whether changes continue after exposure ends. Supportive care can include low-vision tools, lighting changes, and reading aids when central vision is affected. Prevention through correct dosing and regular screening is a major part of long-term safety for higher-risk medications.
Yes. Hydroxychloroquine can cause toxic retinopathy, especially with higher cumulative exposure or added risk factors such as kidney disease. Screening with OCT and visual fields helps detect early damage.
Often, no. Many toxic injuries can leave lasting retinal cell loss, and progression can continue after the drug is stopped in some cases. Early detection offers the best chance to limit the final impact.
OCT and automated visual field testing are commonly used. Fundus autofluorescence and multifocal electroretinography can support confirmation when results are unclear. A clinician selects tests based on risk and exam findings.
Revised Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy. American Academy of Ophthalmology. https://www.aao.org/education/clinical-statement/revised-recommendations-on-screening-chloroquine-h. Date Accessed February 4, 2026.
Hydroxychloroquine Toxicity. EyeWiki. https://eyewiki.org/Hydroxychloroquine_Toxicity. Date Accessed February 4, 2026.
Drug Induced Maculopathy. EyeWiki. https://eyewiki.org/Drug_Induced_Maculopathy. Date Accessed February 4, 2026.
Pentosan Polysulfate Maculopathy. EyeWiki. https://eyewiki.org/Pentosan_Polysulfate_Maculopathy. Date Accessed February 4, 2026.
Chloroquine and Hydroxychloroquine Toxicity. StatPearls (NCBI Bookshelf). https://www.ncbi.nlm.nih.gov/books/NBK537086/. Date Accessed February 4, 2026.